Literature DB >> 16123527

Predicting recovery from schizophrenia: a retrospective comparison of characteristics at onset of people with single and multiple episodes.

Kate Rosen1, Philippa Garety.   

Abstract

A retrospective study was designed to determine whether socio-demographic and clinical factors at onset, previously shown to relate to outcome, differentiated those with a single episode with no persistent symptoms of schizophrenia from other outcome groups. In a geographically determined sample of 436 people with schizophrenia spectrum disorder and a minimum followup period of at least 6 years, 68 people (15.6%) had a single episode with complete remission. The single episode group differed significantly from the rest of the sample at onset on nine variables. On a logistic regression, employment status independently predicted single episodes. Although those with single episodes differed from the rest of the sample on a number of variables, they did not differ significantly at onset from the other better outcome group (repeated episodes without persistent symptoms) on any variables with the exception of insight. Two possibilities are considered: (1) the two better outcome groups differed very little at onset but subsequent treatment or experiences accounted for the differences in outcome; or (2) important differences, not routinely assessed at onset, influenced outcome. The implications of these findings for research into the prevention of relapse in psychosis are considered.

Entities:  

Mesh:

Year:  2005        PMID: 16123527     DOI: 10.1093/schbul/sbi017

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  20 in total

1.  Empowerment and its associations in schizophrenia: a cross-sectional study.

Authors:  Amlan Kusum Jana; Daya Ram; Samir Kumar Praharaj
Journal:  Community Ment Health J       Date:  2014-05-03

2.  Neurobiology of insight deficits in schizophrenia: An fMRI study.

Authors:  Mujeeb U Shad; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2015-05-06       Impact factor: 4.939

3.  Insight and attitudes towards medication among inpatients with chronic schizophrenia in the US and China.

Authors:  Somaia Mohamed; Robert Rosenheck; Hongbo He; Ning Yuping
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-02-19       Impact factor: 4.328

4.  Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia.

Authors:  Somaia Mohamed; Robert Rosenheck; Joseph McEvoy; Marvin Swartz; Scott Stroup; Jeffrey A Lieberman
Journal:  Schizophr Bull       Date:  2008-06-26       Impact factor: 9.306

5.  Mental health laws that require dangerousness for involuntary admission may delay the initial treatment of schizophrenia.

Authors:  Matthew M Large; Olav Nielssen; Christopher James Ryan; Robert Hayes
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-11-30       Impact factor: 4.328

Review 6.  Evidence for a relationship between the duration of untreated psychosis and the proportion of psychotic homicides prior to treatment.

Authors:  Matthew Large; Olav Nielssen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-10-24       Impact factor: 4.328

7.  Scientific and consumer models of recovery in schizophrenia: concordance, contrasts, and implications.

Authors:  Alan S Bellack
Journal:  Schizophr Bull       Date:  2006-02-03       Impact factor: 9.306

8.  Embracing Psychosis: A Cognitive Insight Intervention Improves Personal Narratives and Meaning-Making in Patients With Schizophrenia.

Authors:  Steffen Moritz; Candelaria I Mahlke; Stefan Westermann; Friederike Ruppelt; Paul H Lysaker; Thomas Bock; Christina Andreou
Journal:  Schizophr Bull       Date:  2018-02-15       Impact factor: 9.306

9.  The abilities of improved schizophrenia patients to work and live independently in the community: a 10-year long-term outcome study from Mumbai, India.

Authors:  Amresh Kumar Srivastava; Larry Stitt; Meghana Thakar; Nilesh Shah; Gurusamy Chinnasamy
Journal:  Ann Gen Psychiatry       Date:  2009-10-13       Impact factor: 3.455

10.  Inflammatory and Oxidative Pathways Are New Drug Targets in Multiple Episode Schizophrenia and Leaky Gut, Klebsiella pneumoniae, and C1q Immune Complexes Are Additional Drug Targets in First Episode Schizophrenia.

Authors:  Michael Maes; Aristo Vojdani; Sunee Sirivichayakul; Decio S Barbosa; Buranee Kanchanatawan
Journal:  Mol Neurobiol       Date:  2021-03-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.